Veterinary News,
Explained.

The 2026 AAHA Oncology Guidelines include a section on consultations and referrals, citing AAHA referral guidance and emphasizing coordination when cancer cases need specialty input.

A JAVMA systematic review and meta-analysis examined shorter versus longer antibiotic treatment durations for pneumonia in dogs and cats.

A published study reported that use of a therapeutic renal diet in cats with early chronic kidney disease was associated with slower progression and improved survival.

The 2026 AAHA Oncology Guidelines include a section on technician and team optimization, reinforcing that cancer care in dogs and cats depends on coordinated roles across the practice team.

FDA supplemented approval of Vetmedin to include delaying onset of congestive heart failure in dogs with Stage B2 preclinical myxomatous mitral valve disease.

The 2025 iCatCare consensus guidelines address feline diabetes mellitus, including diagnosis, remission, risk factors, and management of insulin resistance and important comorbidities.

AAHA highlighted major updates to its accreditation standards, including stronger expectations around microchipping conversations and discouraging nontherapeutic procedures without medical indication.

AAHA released 2025 One Health Guidelines encouraging family-centered, cross-disciplinary approaches that link animal, human, and environmental wellbeing.

APHIS announced its 2025 oral rabies vaccination campaign targeting wildlife, describing large-scale bait distribution in multiple states to help prevent spread of raccoon rabies and reduce public-health risk.

AVMA highlighted how better understanding feline behavior can improve diagnosis, clinical interpretation, and the human-animal bond.

AVMA reported on owner underestimation of lifetime pet-care costs and discussed how veterinary teams can better prepare clients for unexpected expenses.

AAHA published practical guidance on adapting routines, home setup, and communication for pets living with blindness or deafness.

APHIS continued field assessment of ONRAB oral rabies vaccine in raccoons and other wildlife, using large-scale bait distribution and follow-up sampling to evaluate immune response in targeted areas.